Current Business Affairs Global Medicinal Cannabis Market 2018

Medicinal Cannabis Market - Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast To 2025
Market Definition:
Medicinal cannabis, or medicinal marijuana, is a therapy that has garnered global attention owing to its application in
treatment of chronic ailments and the controversies surrounding legal, ethical, and societal implications associated with
application. Cannabis has more than hundred active compounds, two of which are -- Cannabidiol (CBD) which does not
alters the consciousness and is used for medicinal properties and another component include delta-9-
tetrahydrocannabinol (THC) which causes intoxication.
Medicinal usage of cannabis is performed to curb disease or health conditions such as blood pressure, memory,
concentration, appetite, sensory stimulus, glaucoma, seizures, weight loss, schizophrenia, multiple sclerosis (MS),
Huntington’s disease, anorexia, chronic motion sickness, failure to thrive in infants and post-traumatic stress disorders
(PTSD) in veterans. Cannabis is also alluring for consumers since it is relatively safer to use as compared to opiates.
Moreover, marijuana is known to be a fantastic muscle relaxant and appears to ease the pain of multiple sclerosis,
lessen the tremors in Parkinson’s and nerve pain. Additionally, medicinal cannabis’s application in treatment of
fibromyalgia, endometriosis, interstitial cystitis, irritable bowel syndrome, Crohn’s disease has been successful.
Furthermore, pain and wasting syndrome associated with HIV and other conditions of chronic pain have also found
cannabis as significant medicine in their treatment methods is projected to accelerate the market growth over forecast
period.
Get PDF with Technological trends at https://www.xpodenceresearch.com/Request-Sample/106910
Market Analysis with Latest Growth Factors:
Growing R&D activities in the medical cannabis market and gradual approval of medicinal cannabis products globally are
also expected to enhance the market growth. For instance, in March, 2017, the German parliament signed a law
allowing the use of cannabis for medicinal purposes if it is prescribed by a medical practitioner to a patient suffering
from severe health issues such as chronic pain, vomiting, and nausea. Moreover, purchase of cannabis products is
allowed from pharmacies on the basis of a valid prescription. However, cultivation of marijuana is still a criminal offence
in many countries. Thus, suppliers depend on other economies to import medicinal cannabis implying a huge potential
for growth of the medicinal cannabis industry in pharmaceutical and biotechnology companies. However, consumption
of cannabis excessively may induce tachycardia or increase the risk of heart attack, particularly for users with existing
heart disease or arrhythmias and is therefore a constraint for the growth of the industry.
Major Key Players: